Dr. Darlene McCord

Dr. Darlene McCord is one of the two founders of McCord Research. As senior researcher, she brings a unique blend of scientific credentials to the position. Through her leadership, the company has achieved worldwide recognition in the OTC Drug and Medical Device categories. Her field of specialty is corneotherapy, focusing on the transport of small molecules across the stratum corneum for treatment of skin disorders associated with distressed and wounded skin. Dr. Darlene E McCord is widely published on subjects related to immunodermatology and corneotherapy.

Dr. Darlene McCord is known for her work, as a biochemist, in skin and wound care. She has been awarded two patents and six medical devices in the field. She currently has more than 30 skin health products being sold around the world. Dr. Darlene McCord’s most current commercialized skin and wound care product offering is the Remedy brand distributed by Medline Industries. The line is based on a proprietary blend of small molecules called Olivamine™ that provide corneotherapeutic support for diseased skin. Previously, Dr. Darlene McCord developed the Restore line for Hollister and the Cavalon line for 3M. She is currently working with the University of Iowa on compounds that may reverse early stages of necrosis and that can activate GO quiescent cells in the chronic wound environment.

Dr. Darlene McCord received her first patent in 1993. The patent and the products developed were immediately licensed to one of the country’s premier wound care companies. Her second patent was awarded in 1997. This patent was licensed immediately and the products have become some of the most important in the wound care industry. The second patent is based upon a fetal in-utero wound healing model and its implications for adult wound healing. Dr. Darlene E McCord continues to pursue her interests in skin repair systems, barrier repair systems, cancer, and diabetes.

Dr. Darlene McCord's work has led to global recognition in the field of skin and wound repair. Her mission remains improving the quality of life for people in every country of the world.

Dr. James McCord

As director of business development Dr. James McCord brings a unique blend of academic administration and business acumen. Through his efforts the company has been able to establish licensing agreements with some of the largest medical companies in the world.

Dr. McCord is a graduate of the University of Iowa were he received all three of his degrees including his Ph.D. in college administration. It is this connection that has lead the company back to Iowa City. Through these Iowa roots Dr. McCord has helped the company locate major collaborative research opportunities. Multiple researchers are now in place and the company is on the path to exciting new technologies.

Among the companies that Dr. McCord developed relationships with are 3M, Hollister, Acme United DeRoyal and Medline Industries. The current contract with Medline Industries is a licensing agreement for the Remedy line that contains Olivamine. McCord Research, Inc developed Olivamine. The combinate ingredient is a patent pending ingredient that has proven to be very effective and is responsible for the Remedy line’s number one position in the hospital skin care market.

Dr. McCord is now working to help the company place its new product line. This line has been in human trials in Ghana and has proven very effective against the Buruli ulcer. Additionally, the company has decided to move into the supplement business and Dr. McCord is actively seeking distribution opportunities in this new and challenging business opportunity.